Phibro Animal Health Corp (NASDAQ:PAHC) VP Daniel M. Bendheim sold 13,162 shares of Phibro Animal Health stock in a transaction that occurred on Monday, March 12th. The shares were sold at an average price of $40.00, for a total transaction of $526,480.00. Following the sale, the vice president now directly owns 3,425 shares of the company’s stock, valued at approximately $137,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Shares of Phibro Animal Health Corp (NASDAQ PAHC) traded up $0.70 during trading hours on Monday, reaching $40.45. 99,710 shares of the company were exchanged, compared to its average volume of 98,011. The company has a market capitalization of $1,630.00, a P/E ratio of 23.65, a price-to-earnings-growth ratio of 2.82 and a beta of 0.97. Phibro Animal Health Corp has a 52 week low of $26.70 and a 52 week high of $40.85. The company has a quick ratio of 1.75, a current ratio of 3.12 and a debt-to-equity ratio of 1.82.
Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Monday, February 5th. The company reported $0.44 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.06. The company had revenue of $205.90 million during the quarter, compared to the consensus estimate of $194.90 million. Phibro Animal Health had a net margin of 7.90% and a return on equity of 40.49%. Phibro Animal Health’s revenue for the quarter was up 7.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.39 earnings per share. equities analysts anticipate that Phibro Animal Health Corp will post 1.69 earnings per share for the current fiscal year.
PAHC has been the subject of several research analyst reports. BidaskClub downgraded shares of Phibro Animal Health from a “hold” rating to a “sell” rating in a research note on Saturday, December 2nd. Zacks Investment Research raised shares of Phibro Animal Health from a “sell” rating to a “hold” rating in a research note on Monday, January 8th. Credit Suisse Group lifted their price target on shares of Phibro Animal Health from $37.00 to $39.00 and gave the company a “neutral” rating in a research note on Tuesday, February 6th. Morgan Stanley lifted their price target on shares of Phibro Animal Health from $30.00 to $36.00 and gave the company an “underweight” rating in a research note on Wednesday, February 7th. Finally, ValuEngine raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Wednesday, February 28th. Three research analysts have rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the stock. Phibro Animal Health has a consensus rating of “Hold” and an average target price of $38.20.
A number of large investors have recently modified their holdings of the stock. Cambridge Investment Research Advisors Inc. raised its stake in Phibro Animal Health by 15.4% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 17,345 shares of the company’s stock worth $581,000 after buying an additional 2,321 shares in the last quarter. MetLife Investment Advisors LLC bought a new position in Phibro Animal Health in the fourth quarter worth approximately $335,000. Municipal Employees Retirement System of Michigan raised its stake in Phibro Animal Health by 32.6% in the fourth quarter. Municipal Employees Retirement System of Michigan now owns 9,610 shares of the company’s stock worth $322,000 after buying an additional 2,360 shares in the last quarter. Millennium Management LLC raised its stake in Phibro Animal Health by 64.3% in the fourth quarter. Millennium Management LLC now owns 419,998 shares of the company’s stock worth $14,070,000 after buying an additional 164,424 shares in the last quarter. Finally, Teachers Advisors LLC raised its stake in Phibro Animal Health by 1.6% in the fourth quarter. Teachers Advisors LLC now owns 352,700 shares of the company’s stock worth $11,815,000 after buying an additional 5,692 shares in the last quarter. 48.09% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION WARNING: This piece of content was first reported by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/03/12/daniel-m-bendheim-sells-13162-shares-of-phibro-animal-health-corp-pahc-stock.html.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.